Genomic multidisciplinary teams: A model for navigating genetic mainstreaming and precision medicine

Aim Recent rapid advances in genomics are revolutionising patient diagnosis and management of genetic conditions. However, this has led to many challenges in service provision, education and upskilling requirements for non‐genetics health‐care professionals and remuneration for genomic testing. In Australia, Medicare funding with a Paediatric genomic testing item for patients with intellectual disability or syndromic features has attempted to address this latter issue. The Sydney Children's Hospitals Network – Westmead (SCHN‐W) Clinical Genetics Department established Paediatric and Neurology genomic multidisciplinary team (MDT) meetings to address the Medicare‐specified requirement for discussion with clinical genetics, and increasing genomic testing advice requests. Methods This SCHN‐W genomic MDT was evaluated with two implementation science frameworks – the RE‐AIM (Reach, Effectiveness, Adoption, Implementation, Maintenance) and GMIR – Genomic Medicine Integrative Research frameworks. Data from June 2020 to July 2022 were synthesised and evaluated, as well as process mapping of the MDT service. Results A total of 205 patients were discussed in 34 MDT meetings, facilitating 148 genomic tests, of which 73 were Medicare eligible. This was equivalent to 26% of SCHN‐W genetics outpatient activity, and 13% of all Medicare‐funded paediatric genomic testing in NSW. 39% of patients received a genetic diagnosis. Conclusion The genomic MDT facilitated increased genomic testing at a tertiary paediatric centre and is an effective model for mainstreaming and facilitating precision medicine. However, significant implementation issues were identified including cost and sustainability, as well as the high level of resourcing that will be required to scale up this approach to other areas of medicine.